The Board of Directors of Hubei Jumpcan Pharmaceutical Co., Ltd. has authorized a buyback plan on July 3, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.68 CNY | -2.88% |
|
+1.24% | +3.98% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.98% | 4.27B | |
+55.55% | 823B | |
+42.31% | 641B | |
-6.83% | 352B | |
+17.15% | 324B | |
+7.09% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- 600566 Stock
- News Hubei Jumpcan Pharmaceutical Co., Ltd.
- Hubei Jumpcan Pharmaceutical Co., Ltd. authorizes a Buyback Plan.